Foghorn Therapeutics, Inc. (FHTX)
5.29
+0.43
(+8.85%)
USD |
NASDAQ |
Apr 17, 16:00
5.27
-0.02
(-0.38%)
After-Hours: 20:00
Foghorn Therapeutics Shareholders Equity (Quarterly) : -108.50M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 26.54B |
| Halozyme Therapeutics, Inc. | 48.81M |
| Vertex Pharmaceuticals, Inc. | 18.67B |
| Verastem, Inc. | 57.20M |
| Fortress Biotech, Inc. | 49.87M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 394.66M |
| Total Liabilities (Quarterly) | 503.16M |
| Debt to Equity Ratio | -0.3804 |
| Current Ratio | 2.732 |
| Net Debt Paydown Yield | -0.14% |